Taking Synthroid at the correct dose does not cause osteoporosis. The link between Synthroid and osteoporosis comes from overreplacement: when the dose is higher than the body needs, thyroid hormone levels run too high, bone breakdown speeds up, and bone density can fall over time. The risk is greatest in postmenopausal women and in people whose TSH is kept deliberately suppressed. Regular blood tests and sensible bone screening keep this risk low.
This guide explains how thyroid hormone affects bone, who is most at risk, which tests to ask about, and how to protect your skeleton while staying on the treatment you need.
What Synthroid Is and Why It Is Prescribed
Synthroid is a brand of levothyroxine, a synthetic version of thyroxine (T4), the main hormone made by the thyroid gland. It is prescribed for hypothyroidism, an underactive thyroid that causes fatigue, weight gain, feeling cold, constipation, dry skin, and low mood.
Levothyroxine replaces the missing hormone, and the body converts some of it into the more active T3. Most people take it for life, which is why its long-term effects on bone matter.
How Thyroid Hormone Affects Bone
Bone is living tissue that is constantly rebuilt through bone remodeling. Osteoclasts break down old bone, and osteoblasts lay down new bone. In healthy adults, the two stay roughly balanced.
Thyroid hormone sets the pace of this cycle. Normal levels keep it steady. Too much thyroid hormone speeds up the whole cycle, but breakdown outpaces rebuilding, so each cycle removes a little more bone than it replaces. Over months to years, this lowers bone mineral density (BMD) and raises fracture risk.
Osteoporosis is the end result: bones that are thinner and more porous, and that break with minor falls. Our overview of osteoporosis covers the condition in more depth.
Correct Dose vs Overreplacement
The single most useful number is TSH (thyroid-stimulating hormone). The pituitary gland raises TSH when thyroid hormone is low and lowers it when thyroid hormone is high, so TSH is a sensitive gauge of whether your dose is right.
| TSH result on levothyroxine | What it suggests | Bone implication |
|---|---|---|
| Within the reference range (roughly 0.4–4.0 mIU/L) | Dose is appropriate for most people | No meaningful added bone risk |
| Mildly low | Slight overreplacement | Small possible effect; dose review usually advised |
| Very low or undetectable | Clear overreplacement or deliberate suppression | Faster bone loss, especially after menopause |
| High | Underreplacement | Not a bone-loss risk, but hypothyroid symptoms persist |
Reference ranges differ slightly between laboratories, and target ranges can be different for older adults and during pregnancy. Some patients treated for thyroid cancer are intentionally kept at a low TSH, which is exactly the group that needs closer bone monitoring.
What About Hypothyroidism Itself?
Untreated hypothyroidism is not good for bone either. Very low thyroid hormone slows remodeling so much that bone quality can suffer, and the fatigue and muscle weakness of hypothyroidism raise the risk of falls.
Starting levothyroxine sometimes causes a small, temporary shift in bone turnover as the body adjusts to normal hormone levels. This settles once the dose is stable and is not the same as the ongoing loss seen with overreplacement.
The practical message is balance. The goal is neither too little nor too much hormone, and TSH testing is the tool that shows where you sit.
Who Is Most at Risk?
Several factors make the Synthroid and osteoporosis connection more important:
- Postmenopausal women: estrogen loss already accelerates bone loss, and excess thyroid hormone adds to it.
- Suppressed TSH: long-term suppression after thyroid cancer, or an unintentionally high dose.
- Older age: needs often fall with age, so a dose that suited you at 40 may be too much at 70.
- Other bone risks: long-term steroids, low body weight, smoking, heavy alcohol use, prior fractures, or a family history of hip fracture.
- Low calcium or vitamin D intake.
Overreplacement also affects the heart, raising the risk of atrial fibrillation, particularly in older adults. Getting the dose right protects more than bone.
Diagnosis and Monitoring
Osteoporosis is usually silent until a fracture, most often of the hip, spine, or wrist. That makes checking before a fracture the goal.
- Thyroid function tests: TSH, with free T4 when needed. TSH is typically rechecked about 6–8 weeks after any dose change, then periodically once stable.
- DEXA scan: dual-energy X-ray absorptiometry measures bone density at the hip and spine.
- Blood tests for bone health: calcium, vitamin D, kidney function, and sometimes other tests to exclude secondary causes of bone loss.
| DEXA T-score | Category |
|---|---|
| −1.0 and above | Normal bone density |
| Between −1.0 and −2.5 | Low bone mass (osteopenia) |
| −2.5 and below | Osteoporosis |
Treatment and Prevention Strategies
The first step is always to optimize the levothyroxine dose. If TSH is suppressed without a specific reason, your doctor will usually lower the dose gradually and recheck. Do not stop or change the dose yourself; untreated hypothyroidism causes its own problems.
If bone density is low, osteoporosis treatment options include bisphosphonates, which slow bone breakdown, denosumab, selective estrogen receptor modulators such as raloxifene, and bone-building drugs for severe cases. The choice depends on fracture risk, kidney function, and personal preference.
Everyday habits also matter:
- Adequate calcium, mainly from food, and enough vitamin D.
- Weight-bearing and muscle-strengthening exercise most days of the week.
- Stopping smoking and keeping alcohol moderate.
- Reducing fall risk at home.
One practical point: calcium and iron supplements reduce levothyroxine absorption. Take levothyroxine on an empty stomach and space these supplements about four hours apart. Our guide to supplements in osteoporosis management covers dosing in more detail.
Key Takeaways
- Synthroid at a dose that keeps TSH in range does not meaningfully harm bone.
- Overreplacement, shown by a low TSH, speeds bone loss over time.
- Postmenopausal women and patients with deliberately suppressed TSH need the closest monitoring.
- Regular TSH checks and DEXA scans for those at risk catch problems early.
- Separate levothyroxine from calcium and iron supplements to keep absorption reliable.
Frequently Asked Questions
Should I stop Synthroid to protect my bones?
No. Stopping it would leave hypothyroidism untreated. The solution is the right dose, confirmed by TSH testing, plus bone screening if you have other risk factors.
How often should my TSH be checked?
Usually about 6–8 weeks after starting or changing the dose, then roughly once a year when stable. Your doctor may check more often if you are older, pregnant, or on TSH suppression.
Can I take calcium with levothyroxine?
Not at the same time. Calcium binds levothyroxine in the gut and lowers absorption. Take levothyroxine first on an empty stomach and the calcium about four hours later.
Do I need a bone density scan if I take Synthroid?
Not automatically. A DEXA scan is recommended based on age, sex, and risk factors, and is reasonable for anyone whose TSH has been suppressed for a long period.
